血造干细胞微移植:当前情况和挑战
Zhengyang Li1, Yuanyuan Yang1, Hongwei Peng2
1Center of Hematology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Therapeutic advances in hematology
|January 6, 2025
概括
血造干细胞微移植 (MST) 通过结合治疗来改善存活率和减少移植对宿主疾病 (GVHD) 为血液恶性瘤提供了一种新的方法. 这种策略增强了移植与瘤的反应,同时保持了免疫功能.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 全基血造干细胞移植 (allo-HSCT) 对血液恶性瘤有效,但受移植对宿主疾病 (GVHD) 的限制,这是死亡的主要原因.
- 尽管如此,GVHD仍然是alo-HSCT的重要障碍,影响患者的治疗结果和生活质量.
研究的目的:
- 审查血液造血干细胞微移植 (MST) 的机制,临床应用和挑战.
- 探索MST的潜力,通过减少GVHD和增强移植与瘤 (GVT) 反应来改善血液恶性瘤的治疗.
主要方法:
- 对血液恶性瘤中MST现有文献的综述.
- 对MST化学疗法,-HSCT和细胞免疫疗法的协同作用组合的分析.
主要成果:
- MST在血液性恶性瘤中表现出有希望的结果,包括改善完全缓解,整体存活率和无进展存活率.
- MST促进了造血的恢复,降低了感染风险,并显著降低了GVHD的发生率.
- 这种方法旨在保持患者的免疫功能,并促进微化学反应,以获得强烈的GVT反应.
结论:
- MST是一种新的治疗策略,有可能克服传统all-HSCT的局限性.
- 进一步了解MST机制可以提高其临床实用性,并将其整合到标准的癌症治疗方案中.
相关概念视频
Bone Marrow Sampling and Transplants
260
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
260
Tissue Transplantation
271
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
271
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K


